186 related articles for article (PubMed ID: 14153049)
41. [Hormonal therapy of metastizing breast cancer].
von Werder K
Med Klin; 1976 Feb; 71(8):313-21. PubMed ID: 56699
[No Abstract] [Full Text] [Related]
42. [Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].
Szepesi T; Schratter-Sehn AU
Wien Klin Wochenschr; 1982 Sep; 94(17):463-9. PubMed ID: 6760557
[TBL] [Abstract][Full Text] [Related]
43. [Possibilities and limitations of endocrine therapy of metastasizing breast cancer].
Nowakowski H
Verh Dtsch Ges Inn Med; 1967; 73():505-18. PubMed ID: 5591802
[No Abstract] [Full Text] [Related]
44. PRESENT MANAGEMENT OF CANCER OF THE BREAST.
FERGUSON DJ
Geriatrics; 1963 Nov; 18():815-26. PubMed ID: 14077869
[No Abstract] [Full Text] [Related]
45. PLASMA CLEARANCE OF CORTISOL AND II-DEOXYCORTISOL IN DOGS.
THOMASSON B; STEENBURG RW
Am J Physiol; 1965 Jan; 208():84-9. PubMed ID: 14253163
[No Abstract] [Full Text] [Related]
46. Hypophysectomy as compared with adrenalectomy in the treatment of advanced carcinoma of the breast.
Fracchia AA; Farrow JH; Miller TR; Tollefsen RH; Greenberg EJ; Knapper WH
Surg Gynecol Obstet; 1971 Aug; 133(2):241-6. PubMed ID: 4105232
[No Abstract] [Full Text] [Related]
47. [PROGNOSIS AND TREATMENT OF BREAST CANCER].
NOTTER G
Nord Med; 1964 Aug; 72():989-95. PubMed ID: 14172483
[No Abstract] [Full Text] [Related]
48. [Current status of hormone therapy in metastasising breast cancer].
Martz G
Clin Ter; 1970 Jan; 52(2):107-13. PubMed ID: 5525590
[No Abstract] [Full Text] [Related]
49. [THE TREATMENT OF BREAST CANCER].
BREHANT J; STOPPA R
Sem Hop; 1963 Sep; 39():1916-21. PubMed ID: 14091085
[No Abstract] [Full Text] [Related]
50. [APROPOS OF ENDOCRINE TREATMENT OF METASTASES FROM BREAST CANCER].
BONTOUX D
Gaz Med Fr; 1964 Feb; 71():585-6. PubMed ID: 14138321
[No Abstract] [Full Text] [Related]
51. THE EFFECTS OF OESTRADIOL ON CORTISOL SECRETION BY THE ISOLATED DOG ADRENAL.
CUSHMAN P; MPULIDO MA; HILTON JG
Acta Endocrinol (Copenh); 1965 Feb; 48():225-33. PubMed ID: 14259894
[No Abstract] [Full Text] [Related]
52. [INFLUENCE OF THE PITUITARY-ADRENAL CORTEX SYSTEM ON ORGAN CHANGES INDUCED BY HEXADIMETHRINE].
TUCHWEBER B; GABBIANI G; SELYE H
Med Welt; 1963 Nov; 45():2272-5. PubMed ID: 14095419
[No Abstract] [Full Text] [Related]
53. [Endocrinic management of metastasizing breast carcinoma in the female].
Nowakowski H
Internist (Berl); 1968 Sep; 9(9):380-8. PubMed ID: 4918658
[No Abstract] [Full Text] [Related]
54. [SIGNIFICANCE OF PITUITARY AND ADRENAL CORTEX HORMONES IN DIABETES MELLITUS].
TAKEDA R; MIYAHO S; MORIMOTO S; HASUI K; KANEDA M; NAGANO T; YOKOYAMA T
Nihon Rinsho; 1964 Apr; 22():835-44. PubMed ID: 14129792
[No Abstract] [Full Text] [Related]
55. The nuclear sex of breast cancer.
Shirley RL
Surg Gynecol Obstet; 1967 Oct; 125(4):737-40. PubMed ID: 6041717
[No Abstract] [Full Text] [Related]
56. Palliative therapy for metastatic breast cancer.
Pigott JD
Postgrad Med; 1980 Mar; 67(3):165-7, 170-2, 174-5 passim. PubMed ID: 6153468
[TBL] [Abstract][Full Text] [Related]
57. PLASMA LEVELS OF CORTISOL, 11-DEOXYCORTISOL AND CORTICOSTERONE DURING "METOPIRONE" TEST.
MATERAZZI F; SABA GC; DEHERTOGH R
Folia Endocrinol; 1964 Jun; 17():356-62. PubMed ID: 14210723
[No Abstract] [Full Text] [Related]
58. ADRENAL CORTICAL SUPPRESSION IN THE RAT; THE EFFECTS OF HYDROCORTISONE WITH AND WITHOUT DESOXYCORTICOSTERONE ACETATE.
CROCKER DW; FAIRGRIEVE J; O'MORCHOE PJ; MOORE FD
J Surg Res; 1964 Dec; 4():562-6. PubMed ID: 14241849
[No Abstract] [Full Text] [Related]
59. Endocrine ablative therapy of metastatic breast cancer.
Binder SC; Flynn WJ; Pass LM
CA Cancer J Clin; 1977; 27(6):354-9. PubMed ID: 73405
[No Abstract] [Full Text] [Related]
60. [The choice of hormone treatment in breast carcinoma].
Schermuly W
Radiologe; 1966 Jan; 6(1):12-22. PubMed ID: 4165533
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
